M. Cakan Et Al. , "Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections," CLINICAL RHEUMATOLOGY , vol.39, no.1, pp.249-253, 2020
Cakan, M. Et Al. 2020. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections. CLINICAL RHEUMATOLOGY , vol.39, no.1 , 249-253.
Cakan, M., Aktay Ayaz, N., KESKİNDEMİRCİ, G., Karadag, S. G., Tanatar, A., & Sonmez, H. E., (2020). Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections. CLINICAL RHEUMATOLOGY , vol.39, no.1, 249-253.
Cakan, Mustafa Et Al. "Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections," CLINICAL RHEUMATOLOGY , vol.39, no.1, 249-253, 2020
Cakan, Mustafa Et Al. "Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections." CLINICAL RHEUMATOLOGY , vol.39, no.1, pp.249-253, 2020
Cakan, M. Et Al. (2020) . "Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections." CLINICAL RHEUMATOLOGY , vol.39, no.1, pp.249-253.
@article{article, author={Mustafa Cakan Et Al. }, title={Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections}, journal={CLINICAL RHEUMATOLOGY}, year=2020, pages={249-253} }